Biomarkers for Oncology
JH · Effective Oct 1, 2015
153 active Medicare policies list C18.9, and 14 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 153
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
14 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C18.9 |
|---|---|---|
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |
| Gonadotropin-Releasing Hormone Analogs and Antagonists | Jul 14, 2023 | Covered |
| Liver and Other Neoplasms - Treatment Approaches | May 4, 2023 | Covered |
| Panitumumab (Vectibix) | Feb 5, 2024 | Covered |
| Pharmacogenetic and Pharmacodynamic Testing | Feb 27, 2024 | Covered |
| Radiofrequency Tumor Ablation | Oct 6, 2023 | Covered |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Sep 24, 2018
JM · Effective Sep 24, 2018
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Aug 21, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Oct 1, 2015
JE · Effective Jul 5, 2016
JF · Effective Jul 5, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
J6 · Effective Jul 1, 2026
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2025
J5 · Effective Jul 16, 2026
National · Effective Jan 22, 2026
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Sep 27, 2026
National · Effective Mar 5, 2026
| Tumor Markers | Mar 5, 2024 | Covered |
|---|
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |
|---|
| Virtual Gastrointestinal Endoscopy | Jul 21, 2023 | Covered |
|---|
| Zoledronic Acid | Feb 1, 2024 | Covered |
|---|
| Policy | Effective | Status of C18.9 |
|---|---|---|
| Cryosurgical, Radiofrequency, Microwave, or Percutaneous Ethanol Ablation to Treat Solid Tumors in the Liver | Apr 15, 2026 | Covered |
| Wireless Capsule Endoscopy for Gastrointestinal Imaging and the Patency Capsule | Oct 1, 2026 | Covered |
| Policy | Effective | Status of C18.9 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
| Policy | Effective | Status of C18.9 |
|---|---|---|
| Low-Level Laser and High-Power Laser Therapy | Mar 15, 2026 | Covered |